Question 1

How does Owkin's AI technology enhance precision medicine and accelerate clinical trials in healthcare?

Accepted Answer

Owkin leverages advanced agentic AI combined with world-class multimodal patient data—including clinical records, genomic sequencing, and spatial multi-omics—to understand complex biology and identify precision therapeutics. This approach enables de-risking and speeding up of clinical trial processes by generating robust patient outcome models and actionable biomarkers, thus facilitating faster and more precise drug development and diagnostics in oncology and other critical fields

Question 2

What makes Owkin's AI diagnostic solutions unique and beneficial for routine clinical workflows?

Accepted Answer

Owkin offers clinically validated AI diagnostics that support pathologists by providing quick, standardised interpretation of whole slide images and screening biomarkers to prioritise patients for molecular tests. Its AI reduces lab workload, accelerates diagnosis times (minutes vs. weeks), and produces standardised reports, improving diagnostic efficiency and patient outcomes. Owkin's solutions are platform-agnostic, plug-and-play, and regulatory-approved, making them easy to integrate into diverse healthcare IT environments.

Question 3

How does Owkin ensure data privacy and collaboration in its AI-driven healthcare research?

Accepted Answer

Owkin employs pioneering federated learning technology that allows AI models to be trained on sensitive patient data across multiple institutions without transferring or centralising the data itself. This privacy-enhancing approach enables secure global collaboration among top hospitals and research centres while complying with data protection regulations, thus maintaining patient confidentiality and fostering data access at scale.

Useful Links

Our Services

Contact Us